13 results
8-K
EX-99.1
COYA
Coya Therapeutics Inc
21 Aug 23
Former CEO and Chairman of the Board of Bayer Pharma AG, Dieter Weinand, joins Coya’s Board of Directors
5:01pm
and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Mr. Weinand is a seasoned business
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
. Dr. Goldstein brings over 20 years of strategic financial and operational experience within the healthcare sector. He currently serves as the Chief … Analysis at HealthCare Ventures LLC. Dr. Goldstein currently serves on the board of directors of NeuBase Therapeutics, Inc. (Nasdaq:NBSE) and Gain
10-K
t87g75uvq apcdbfac
29 Mar 23
Annual report
4:08pm
424B4
ptn08wlj3x
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
3j212
5 Dec 22
IPO registration (amended)
8:16am
S-1
q6nycy0f56iw3
18 Nov 22
IPO registration
5:06pm
DRS/A
3z39qqxhu 7nlrk7wb8
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
ytxmi0bg5 jfu28
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
n5f0d 1gs8z6u
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next